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Abstract
Background There are limited data on skin lesions in children
with end-stage renal failure. The aim of the study was an
evaluation of the skin barrier in children with different stages
of chronic kidney disease (CKD). The prevalence of xerosis,
its severity, as well as its link selected demographic factors,
were examined.
Methods The study included 103 children: 72 with CKD
stages 3–5 (38 on conservative treatment and 34 on dialysis)
and 31 patients with primary monosymptomatic nocturnal
enuresis as a control group. Initially, the study subjects de-
scribed the localisation and severity of dry skin by themselves.
Next, clinical evaluation of xerosis, non-invasive
corneometric assessment of epidermis moisturising and the
measurement of transepidermal water loss were performed.
Results Most CKD children reported dry skin. The problem
of xerosis was identified more frequently in patients on dial-
ysis (67.6 %) than on conservative treatment (42.1 %) (p=
0.01). CKD patients divided according to skin dryness did not
differ with regards to age, sex, initial kidney disease and CKD
duration.
Conclusions Disturbed skin barrier is an important concern of
children with CKD, intensifying as the disease progresses.
This symptom occurs on early stages of CKD and it should
be taken into consideration in the CKD management.
Keywords Dry skin . Chronic kidney disease . Dialysis .
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Introduction
Chronic kidney disease (CKD), regardless of its cause, may be
accompanied by various skin lesions. The most common
symptom in adults suffering from CKD is pruritus. Other
signs include xerosis, skin hyperpigmentation, ecchymoses,
acquired perforating dermatoses, nail lesions, calcinosis cutis,
porphyria cutanea tarda, as well as eczematous lesions at the
site of an arteriovenous fistula and skin infections [1–3].
Dry skin is a common problem in patients with CKD.
Thomas et al. [1] reported its presence in 66.7 % of adult
patients with CKD. Other authors showed similar results [2, 4,
5]. Histopathological examination of the skin of CKD patients
reveals microangiopathy, atrophy of the epidermis, sebaceous
glands, secretory tubules and ducts of the eccrine glands,
hyperkeratosis and elastin fibre fragmentation [6–8].
Diminished sweat secretion lowers skin hydration and impairs
elimination of electrolytes, urea, amino acids, proteins and
lipids [9, 10]. The level of glycerol—one of the relevant
endogenous humectants and a component of a natural
moisturising factor—is also decreased. Xerosis may be ob-
served in all skin areas; however, in some patients it is more
severe on the lower legs [8]. Skin dryness may appear at
various stages of CKD, but it is more frequently diagnosed
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in dialysis subjects (45 %) [11]. The data regarding the clinical
relevance of skin dryness in patients with CKD are very
limited. However, it seems probable that the disturbed skin
barrier observed in xerosis may facilitate the development of
skin infections.
There are very limited data on skin lesions in children with
CKD. Only a few papers concerning xerosis in paediatric
patients have been published and they present the results of
studies on a small number of patients who needed renal
replacement therapy [2, 11, 12]. An assessment of the skin
barrier in childrenwith CKD in the earlier stages of the disease
could not be found in the contemporary literature; therefore,
we conducted a study with the aim of evaluating skin dryness
in children with different stages of CKD. The prevalence of
xerosis, its severity, as well as its link with selected demo-
graphic factors characteristic of CKD, were examined.
Materials and methods
Patients
The study involved 103 children from three Polish paediatric
nephrology centres located in Wroclaw, Krakow and Zabrze.
It included 72 patients with CKD at stages 3–5 [13] and 31
patients with primary monosymptomatic nocturnal enuresis as
a control group. Thirty-eight patients with CKD were given
conservative treatment and 34 were provided with renal re-
placement therapy (20 haemodialysis subjects and 14 perito-
neal dialysis subjects). All dialysis patients were combined
into one group, as the numbers of patients who were subjected
to haemodialysis and peritoneal dialysis were low.
Children with CKD had not been on any dermatological
treatment, nor had any of them suffered from any infection or
other condition (including atopic dermatitis), which might
significantly influence the skin hydration, for at least 4 weeks
before enrolment into our study. Haemodialysis was per-
formed three times a week for 4 h using polysulphone
dialysers. Patients underwent dialysis using acetate and bicar-
bonate concentrate with standard potassium and calcium con-
centrations. All assessments were conducted during
hospitalisation on days when haemodialysis was not per-
formed. In the group of patients treated with peritoneal dialy-
sis an automated peritoneal dialysis (APD) method was used.
Baxter Peritoneal Dialysis Solutions (1.36 % glucose) were
administered. Physioneal® and/or Extranil® were used if re-
quired. APD lasted 12 h on average. The examination was
carried out during the patient’s stay in the nephrology centre.
None of children in the control group suffered from any
chronic disease, except for primary monosymptomatic noc-
turnal enuresis. The children did not receive any pharmaco-
therapy, nor did they suffer from any acute infection or other
acute condition within the period of 4 weeks before the study.
Before entering the study, children and their caretakers
gave informed consent to participation in the study; they were
also informed of their right to leave the study at any time. The
study protocol was approved by the Bioethics Committee at
the Wroclaw Medical University (opinion KB-751/2012).
Study design
The skin barrier in children was assessed using several
methods. Initially, all study subjects were asked to describe
the location and severity of skin xerosis using the terms
absent, mild, moderate or severe dryness. If necessary, the
severity of skin xerosis was reported with the help of parents
(especially in very young children). Next, a clinical evaluation
of skin dryness, a non-invasive corneometric assessment of
epidermis moisturising and a measurement of transepidermal
water loss (TEWL) using a tewameter were performed. All
measurements were performed on four areas of the skin: the
forearm, the lower leg, the abdomen and the chest under stable
environmental conditions: temperature 20–22 °C and air hu-
midity 40–50 % after a 10-min rest in the sitting position.
Evaluation of xerosis
Clinical evaluation of xerosis was conducted using the stan-
dard clinical four-point Xerosis Assessment Scale (0—normal
skin, without any xerosis; 1—mild xerosis; 2—moderately
dry skin with minimal flaking; 3—severe xerosis, heavy scal-
ing visible). This scale has been used in a number of previous
studies on xerosis [14, 15].
Corneometric assessment of epidermis moisture
The assessment of epidermis moisturising was performed
using a Corneometer CM825 produced by Courage +
Khazaka Electronic (Cologne, Germany). This measurement
is based on the different dielectric constants of water and other
substances. The measuring capacitor shows changes in capac-
itance according to the moisture content of the samples. An
electric scatter field penetrates the skin during the measure-
ment and the dielectricity is determined. Results achieved
using the Corneometer are demonstrated in arbitrary units
(AU). A lowering of these values indicates a decrease in the
water content in the outer layers of the epidermis.
Assessment of transepidermal water loss
Transepidermal water loss was performed using a Tewameter
TM300 produced by Courage +Khazaka Electronic. A certain
evaporation of water from the skin always takes place as part
of the normal skin metabolism. As soon as the barrier function
of the skin alters, the water loss increases. Therefore, this
measurement remains the basis for much cosmetic and
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dermatological research. The Tewameter® probe measures the
density gradient of the water evaporation from the skin by two
pairs of sensors (temperature and relative humidity) inside the
hollow cylinder. A microprocessor analyses the gradient of
these values and after calculation expresses the evaporation
rate in g/h/m2.
Statistical analysis
Contingencies and frequencies (percentage values) were cal-
culated for qualitative parameters, while means and standard
deviations for normally distributed quantitative variables or
medians and quartiles for skewed variables were measured.
All data were processed using Microsoft Office Excel 2010
software (Microsoft Corporation, Warsaw, Poland) and
Statistica 10.0 (StatSoft, Krakow, Poland). Chi-squared test,
Student’s t test, the Mann–Whitney U test, analysis of
variance and Spearman rank correlation test were used,
where appropriate. The statistical significance level was set
at 0.05.
Results
The demographic data of the groups studied are presented in
Table 1. The most common cause of CKD was congenital
malformation of the urinary tract, which was present in 36
patients (50 %): 23 of them (32 %) were on conservative
treatment and 13 (18 %) were on dialysis. Other patients had
CKD resulting from polycystic kidney disease—13 children
(18 %; 7 on conservative treatment and 6 on dialysis), chronic
glomerulonephritis—10 children (14 %; 3 on conservative
treatment and 7 on dialysis), acute tubulointerstitial nephri-
tis—8 children (11 %; 4 on conservative treatment and 4 on
dialysis). The remaining 5 children (7 %) had Alport syn-
drome, tubulopathy or other, unknown causes—1 patient
underwent conservative treatment and 4 had dialysis.
Table 2 shows the results of a questionnaire on the preva-
lence, severity and site of skin dryness in the study subjects.
The vast majority of children in the control group (81.1 %) did
not report any skin dryness. This problem, however, was
frequently reported by the CKD patients, more often in those
undergoing dialysis (67.6 % of them) than in the patients
receiving conservative treatment (42.1 %; overall, 54.2 %
patients with CKD had dry skin symptoms). The differences
between the control group and the study group, as well as
between the two groups of patients with CKD, were statisti-
cally significant (p<0.001 and p=0.03 respectively). Children
from the control group reported skin dryness exclusively on
the forearm and lower legs; the patients with CKD addition-
ally reported this symptom on the abdomen and the chest.
Detailed data are provided in Table 2.
In the control group the median duration of skin dryness
was 2 years (25 –75 %: 1–15, range: 1–15), and in CKD
patients undergoing conservative treatment and dialysis it
was 6 years (25–75 %: 3–8, range: 0.5–15) and 8 years (25–
75 %: 3.7–14, range: 1.5–17) respectively. The differences
observed were not statistically significant (p=0.31). The sub-
groups of CKD patients created based on the presence of skin
dryness did not differ with regard to age (p=0.3), sex (p=
0.77), initial kidney disease (p=0.43) and the duration of
CKD (p=0.43). A statistically significant difference was ob-
served for the severity of skin dryness in the abdominal area
and lower legs between the CKD and the control group. No
Table 1 Characteristics of the
examined groups. Continuous
data given as means ± SD
(without range)
CKD chronic kidney disease
Control group
n=31
CKD on
conservative
treatment
n=38
CKD on dialysis
N=34
p
Age (years) 10.7±3.9 11.0±4.5 11.1±4.2 0.95
Gender: female/male (%) 17/14 (54.8/45.2) 8/30 (21.1/78.9) 22/12 (64.7/35.3) <0.001
Cause of CKD
Anomaly of the urinary tract – 23 (60.5) 13 (38.2) 0.2
Polycystic kidney disease – 7 (18.4) 6 (17.6)
Chronic glomerulonephritis – 3 (7.9) 7 (20.6)
Chronic interstitial nephropathy – 4 (10.5) 4 (11.8)
Other – 1 (2.6) 4 (11.8)
CKD duration (years) – 7.3±4.9 7.4±4.8 0.98
CKD stage
3 – 20 0
4 – 18 0
5 – 0 34
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significant differences were noted with regard to the clinical
evaluation of skin dryness at other sites (Table 3).
There were statistically significant differences between the
groups regarding epidermis moisturising on the forearm, low-
er leg, abdomen and chest. A significant difference was also
noted in the thoracic area for patients on conservative treat-
ment and undergoing dialysis, as well as in the forearm and
lower leg between the control group and other groups (as well
as between CKD patients treated with different methods) with
regard to TEWL (Table 3). Correlations between the subjec-
tive assessment of dry skin and TEWL and corneometry for all
children are demonstrated in Table 4.
Discussion
In this study concerning the paediatric population, skin dry-
ness was considerably more frequently reported by children
with CKD (54.2 %) than by children from the control group
(18.9 %). Children with CKD undergoing dialysis reported
skin dryness more often than those receiving conservative
treatment. Similar data were described by other authors in
adults with CKD. Anderson et al. [16] estimated that 50–
70 % of adults on dialysis suffer from xerosis. In the study
by Thomas et al. [1] the total prevalence of skin dryness in
adults with different stages of CKD was 66.7 %, and in most
cases affected haemodialysis patients. In the recently pub-
lished study by Kolla et al. [17], including the group of 100
patients undergoing haemodialysis, aged 49±12.3 years, skin
dryness was the most common cutaneous problem, and was
observed in 78.3 % subjects.
A slightly lower prevalence of dry skin in our study com-
pared with data of other authors may be associated with the
severity of CKD and the patient’s age. To the best of our
knowledge this is the first study to evaluate skin moisture in
children with CKD undergoing conservative treatment.
Studies on adults with CKD mainly included patients on
maintenance dialysis [5, 11, 18, 19]. In addition, cutaneous
lesions may develop with aging of the skin [20]. Xerosis may
also be influenced by such factors as race, accompanying
illnesses and various environmental factors [21]. Nowadays,
various devices allowing the evaluation of epidermis
moisturising and TEWL are available, as were also used in
our study. These methods of skin barrier assessment allowed
us to standardise the subjective data obtained from the sub-
jects studied.
In our study, skin dryness was more frequently reported on
forearms and lower legs than at other sites. Similar results
regarding the localisation of xerosis in adults undergoing
haemodialysis were reported by Udayakumar et al. [2] and
by Kato et al. [22]. However, some other authors stated that
skin dryness in CKD patients may be present anywhere.
Morton et al. [5] observed skin dryness in adults undergoing
haemodialysis and peritoneal dialysis in all the areas exam-
ined with the greatest severity on the back. In their study the
differences between haemodialysis and peritoneal dialysis
subjects with regard to xerosis severity were noticeable, with
more severe dryness in the first group. Results of corneometric
examination were comparable with those of clinical xerosis
assessments. Patients undergoing peritoneal dialysis had less
skin moisture than patients undergoing haemodialysis and
healthy controls in all the areas studied. Moreover, a signifi-
cant correlation between lower moisturising of the stratum
corneum and itching was found in both groups [5].
A complex analysis based on various methods leads us to
the conclusion that more children suffering from CKD had
skin dryness than healthy children and that it was most severe
Table 2 Prevalence, severity and site of skin dryness and pruritus in the
study subjects
Control
group,
n (%)
CKD patients
on conservative
treatment, n (%)
CKD patients
on dialysis,
n (%)
p
Skin dryness
None 27 (81.1) 22 (57.9) 11 (32.4) <0.001
Mild 4 (12.9) 15 (39.5) 17 (50.0)
Moderate 0 (0) 1 (2.6) 6 (17.6)
Prevalence of dry skin
Forearm 3 (9.7) 3 (7.9) 8 (23.5) 0.12
Lower leg 3 (9.7) 9 (23.7) 12 (35.3) 0.05
Abdomen 0 (0) 3 (7.7) 5 (14.7) 0.09
Chest 0 (0) 1 (2.6) 4 (11.8) 0.06
Presence of pruritus 0 (0) 7 (18.4) 8 (23.5) 0.01
CKD chronic kidney disease
Table 3 Assessment of dry skin (results demonstrated as mean ± SD)
Control
group
CKD patients on
conservative
treatment
CKD patients
on dialysis
p
Clinical evaluation of dry skin
Forearm 0.1±0.3 0.13±0.41 0.24±0.43 0.35
Lower leg 0.1± 0.3 0.3±0.5 0.4±0.5 0.03
Abdomen 0 0.1±0.3 0.2±0.5 0.04
Thorax 0 0.03±0.2 0.1±0.3 0.13
Epidermis moisturising (corneometry; AU)
Forearm 31.2±6.2 30.4±0.9.8 28.4±5.7 0.32
Lower leg 31.8±7.7 25.9±7.2 24.5±6.6 <0.001
Abdomen 35.6±7.8 29.5±0.10.1 25.1±7.0 <0.001
Thorax 45.5±7.8 40.4±13.5 33.8±7.7 <0.001
Transepidermal water loss (g/m2/h)
Forearm 5.5±2.9 8.5±4.1 8.3±3.1 <0.001
Lower leg 6.7±3.6 7.9±5.0 9.8±5.3 0.04
Abdomen 6.9±5.3 9.6±6.4 9.2±5.5 0.12
Thorax 6.7±3.7 9.5±6.8 7.6±3.3 0.06
CKD chronic kidney disease
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in patients on dialysis. It is very likely, that, similar to adult
subjects [23], uremic xerosis may cause a significant decrease
in the quality of life in children, although relevant data are
lacking. Because skin dryness in CKD patients on dialysis
was much more prevalent, more severe and covered larger
areas than in other types of xerosis, in the past it was given the
unique name uraemic xerosis [8]. Moreover, many studies
suggested that uraemic xerosis is an important factor for
uraemic pruritus [24–27]. Dry skin may also be a problem in
healthy people. It is estimated that it affects about 15–20 % of
general population [28]. However, unlike “physiological” dry
skin, uraemic xerosis is typically associated with abnormali-
ties in deeper layers of the epidermis (such as atrophy of sweat
and sebaceous glands and their impaired secretory function),
which may lead to decreased epidermis moisturising [8]. One
of the possible causes of dry skin in dialysis patients may be
abnormal pH in the stratum corneum [8, 25]. Elias et al. [29]
pointed to pH level as one of the possible factors regulating
the natural process of skin exfoliation in patients with
ichthyosis. Decreased pH on the skin surface may activate
various proteases, which play a role in stratum corneum
exfoliation. It was observed that the pH of the stratum
corneum is increased in dialysis patients [20], which may
interrupt protease activation and, consequently, cause skin
barrier dysfunction and xerosis in patients undergoing dialysis
[8]. Remarkably, in adults undergoing haemodialysis, the use
of emollients significantly reduced the dry skin and raised the
quality of life of patients [23, 30]. In our opinion, emollients
(applied at least two to three times a day) with/without oil
baths are also the mainstay of the treatment of skin dryness in
children with CKD. If necessary, keratolytics may be added,
especially in older children.
There are some limitations of our study. The number of
children with CKD is not large, but it seems to be represen-
tative. It has to be stressed that the population of children
suffering from CKD is considerably smaller than the popu-
lation of adult CKD patients. It is difficult to conduct such a
study on a higher number of paediatric patients, since it is
crucial to maintain the same conditions of the examinations
and ensure that the examinations are performed by the same
qualified dermatologist in order to provide uniform assess-
ment criteria. In the future the difference between
haemodialysis and peritoneal dialysis patients should be
studied, as described for adult patients. Furthermore, the
differences observed in 1 unit of TEWL between patients
on dialysis and those on conservative treatment may be
clinically meaningless, even though they are statistically
significant.
In conclusion, dry skin seems to be a relevant problem in
children with CKD. Xerosis was more prevalent in patients
with CKD than in the reference group and in dialysed patients
compared with patients undergoing conservative treatment,
which indicates that it is aggravated with the progression of
kidney function impairment. However, skin xerosis may also
occur in the early stages of CKD and it should be taken into
consideration when planning treatment in order to prevent
skin lesion progression and improve the quality of life of
children with CKD.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Thomas EA, Pawar B, Thomas A (2012) A prospective study of
cutaneous abnormalities in patients with chronic kidney disease.
Indian J Nephrol 22:116–120
2. Udayakumar P, Balasubramanian S, Ramalingam KS, Lakshmi C,
Srinivas CR, Mathew AC (2006) Cutaneous manifestations in pa-
tients with chronic renal failure on hemodialysis. Indian J Dermatol
Venereol Leprol 72:119–125
3. Amatya B, Agrawal S, Dhali T, Sharma S, Pandey SS (2008) Pattern
of skin and nail changes in chronic renal failure in Nepal: a hospital-
based study. J Dermatol 35:140–145
4. Khanna D, Singal A, Kalra OP (2010) Comparison of cutaneous
manifestations in chronic kidney disease with or without dialysis.
Postgrad Med J 86:641–647
5. Morton CA, Lafferty M, Hau C, Henderson I, Jones M, Lowe JG
(1996) Pruritus and skin hydration during dialysis. Nephrol Dial
Transplant 11:2031–2036
6. Gilchrest BA, Rowe JW, Mihm MC Jr (1980) Clinical and histolog-
ical skin changes in chronic renal failure: evidence for a dialysis-
resistant, transplant-responsive microangiopathy. Lancet 13:1271–
1275
Table 4 Correlations between the subjective assessment of skin dryness and corneometry and transepidermal water loss (TEWL) for all subjects
(n=103)
Clinically assessed skin dryness
Forearm Lower leg Abdomen Chest
Epidermis moisturising (corneometry) R=−0.38, p<0.001 R=−0.52, p<0.001 R=0.33, p<0.001 R=−0.32, p=0.001
TEWL R=0.09, p=0.38 R=0.13, p=0.2 R=0.13, p=0.2 R=0.18, p=0.07
TEWL transepidermal water loss
Pediatr Nephrol (2015) 30:333–338 337
7. Landing BH, Wells TR, Williamson ML (1970) Anatomy of eccrine
sweat glands in children with chronic renal insufficiency and other
fatal chronic diseases. Am J Clin Pathol 54:15–21
8. Szepietowski JC, Reich A, Schwartz R (2004) Uraemic xerosis.
Nephrol Dial Transplant 19:2709–2712
9. Ponticelli C, Bencini PL (1992) Uremic pruritus: a review. Nephron
60:1–5
10. Yosipovitch G, DuqueMI, Patel TS, Ishiuji Y, Guzman-Sanchez DA,
Dawn AG, Freedman BI, Chan YH, Crumrine D, Elias PM (2007)
Skin barrier structure and function and their relationship to pruritus in
end-stage renal disease. Nephrol Dial Transplant 22:3268–3272
11. Attia EA, Hassan SI, Youssef NM (2010) Cutaneous disorders in
uremic patients on hemodialysis: an Egyptian case-controlled study.
Int J Dermatol 49:1024–1024
12. Akhyani M, Ganji MR, Samadi N, Khamesan B, Daneshpazhooh M
(2005) Pruritus in hemodialysis patients. BMC Dermatol 5:7
13. National Kidney Foundation (2002) K/DOQI clinical practice guide-
lines for chronic kidney disease: evaluation, classification and strat-
ification. Am J Kidney Dis 39[Suppl 1]:S1–S266
14. Cook T, Craft TJ (1985) Topographics of dry skin, non-dry skin, and
cosmetically treated dry skin as quantified by skin profilometry. J Soc
Cosmet Chem 36:143–152
15. Eberlein-König B, Schäfer T, Huss-Marp J, Darsow U,
Möhrenschlager M, Herbert O, Abeck D, Krämer U, Behrendt H,
Ring J (2000) Skin surface pH, stratum corneum hydration, trans-
epidermal water loss and skin roughness related to atopic eczema
and skin dryness in a population of primary school children. Acta
Derm Venereol 80:188–191
16. Anderson CK (2002) Asteatotic eczema. EMed J. Available at http://
emedicine.com/derm/topic538.htm
17. Kolla PK, Desai M, Pathapati RM, Mastan Valli B, Pentyala S,
Madhusudhan Reddy G, Vijaya Mohan Rao A (2012) Cutaneous
manifestations in patients with chronic kidney disease on mainte-
nance hemodialysis. ISRN Dermatol 2012:679619. doi:10.5402/
2012/679619
18. Tajbakhsh R, Dehghan M, Azarhoosh R, Haghighi AN, Sadani S,
Zadeh SS, Kabootari M, Qorbani M (2013) Mucocutaneous mani-
festations and nail changes in patients with end-stage renal disease on
hemodialysis. Saudi J Kidney Dis Transpl 24:36–40
19. Onelmis H, Sener S, Sasmaz S, Ozer A (2012) Cutaneous changes in
patients with chronic renal failure on hemodialysis. Cutan Ocul
Toxicol 31:286–291
20. Yalçin B, Tamer E, Toy GG, Oztaş P, Hayran M, Alli N (2006) The
prevalence of skin diseases in the elderly: analysis of 4099 geriatric
patients. Int J Dermatol 45:672–676
21. Markova A, Lester J, Wang J, Robinson-Bostom L (2012) Diagnosis
of common dermopathies in dialysis patients: a review and update.
Semin Dial 25:408–418
22. Kato A, Hamada M, Maruyama T, Maruyama Y, Hishida A (2000)
Pruritus and hydration state of stratum corneum in hemodialysis
patients. Am J Nephrol 20:437–442
23. Szepietowski JC, Balaskas E, Taube KM, Taberly A, Dupuy P,
Uraemic Xerosis Working Group (2011) Quality of life in patients
with uraemic xerosis and pruritus. Acta Derm Venereol 91:313–317
24. Ostlere LS, Taylor C, Baillod R, Wright S (1994) Relationship
between pruritus, transepidermal water loss, and biochemical
markers of renal itch in haemodialysis patients. Nephrol Dial
Transplant 9:1302–1304
25. Yosipovitch G, Tur E, Morduchowicz G, Boner G (1993) Skin
surface pH, moisture, and pruritus in haemodialysis patients.
Nephrol Dial Transplant 8:1129–1132
26. Zucker I, Yosipovitch G, David M, Gafter U, Boner G (2003)
Prevalence and characterization of uremic pruritus in patients under-
going hemodialysis: uremic pruritus is still a major problem for patients
with end-stage renal disease. J Am Acad Dermatol 49:842–846
27. Yosipovitch G (2004) Dry skin and impairment of barrier function
associated with itch - new insights. Int J Cosmet Sci 26:1–7
28. Wojnowska D, Chodorowska G, Juszkiewicz-Borowiec M (2003)
Xerosis –pathogenesis, clinical symptoms ant treatment. Adv Derm
Alerg 2:98–105
29. Elias PM, Crumrine D, Rassner U, Hachem JP, Menon GK, Man W,
Choy MH, Leypoldt L, Feingold KR, Williams ML (2004) Basis for
abnormal desquamation and permeability barrier dysfunction in
RXLI. J Invest Dermatol 122:314–319
30. Balaskas E, Szepietowski JC, Bessis D, Ioannides D, Ponticelli C,
Ghienne C, Taberly A, Dupuy P (2011) Randomized, double-blind
study with glycerol and paraffin in uremic xerosis. Clin J Am Soc
Nephrol 6:748–752
338 Pediatr Nephrol (2015) 30:333–338
